Amgen Set to Share Insights at the Bank of America Merrill Lynch Global Healthcare Conference

Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference

Amgen, a leader in biopharmaceutical innovation, announces its participation in the Bank of America Merrill Lynch Global Healthcare Conference, taking place on May 13, 2026, at 10:00 a.m. PT. This event will be an opportunity for Amgen to share insights into its recent advancements and ongoing commitment to addressing serious medical conditions through innovative therapies.

Overview of the Conference

The Global Healthcare Conference is a significant event where industry leaders, investors, and media representatives gather to discuss the future of healthcare and biotechnology. Amgen's executive vice president and chief financial officer, Peter Griffith, alongside Jay Bradner, the executive vice president of Research and Development, will lead the presentation. Their discussions will spotlight Amgen's strategic initiatives and research breakthroughs that promise to enhance patient care.

This presentation will be available via a live webcast, ensuring accessibility for a wider audience, including investors, members of the media, and the public. This commitment to transparency highlights Amgen’s dedication to keeping its stakeholders informed about its progress and plans. The webcast will also later be archived for those unable to attend the live session, available for playback for at least 90 days post-event.

About Amgen

Founded over 45 years ago in Thousand Oaks, California, Amgen has been at the forefront of biotechnology, transforming how diseases are treated through innovative medicines. The company specializes in discovering, developing, manufacturing, and delivering crucial therapies for devastating diseases such as cancer, heart disease, and rare genetic disorders. By leveraging advanced biotechnological methods and human genetic research, Amgen continues to expand its pipeline, aiming to improve the lives of millions of patients worldwide.

The company's reputation for excellence is bolstered by numerous accolades for workplace culture and innovation, underscoring its status as one of the leading entities in the sector. Amgen not only contributes significantly to healthcare advancements but also plays a pivotal role in the economic landscape, recognized as one of the 30 major companies in the Dow Jones Industrial Average® and part of the Nasdaq-100 Index®.

Looking Ahead

As Amgen prepares for the upcoming conference, anticipation builds around the potential announcements and insights that may emerge. The healthcare industry constantly evolves, with biotechnology driving much of this change. Amgen’s commitment to innovation ensures it remains a key player in this dynamic field, navigating the challenges of modern medicine and addressing the urgent needs of patients.

For further details about Amgen, its innovative solutions, and to access the webcast from the conference, please visit www.amgen.com. Follow Amgen on various social media platforms for the latest updates and insights into the company's research and initiatives.

The upcoming conference underscores Amgen's role not just as a biopharmaceutical company, but as a leader in fostering discussions around healthcare innovation and patient care. With a strong foundation in science and a commitment to community well-being, Amgen is set to play a pivotal role in shaping the future of healthcare.

For media inquiries, please contact: